The FDA needs to be held accountable.

EpiPen has NEVER had clinical trials before being approved and the FDA is using that as a reason to deny safer, needle-free, more stable , and more effective treatments for an EpiPen alternative (that are also hundreds of dollars less than EpiPen).

You are viewing a robot-friendly page.Click hereto reload in standard format.